VLE THERAPEUTICS LIMITED

VLE Therapeutics Limited is a specialised contract development and manufacturing organisation (CDMO) that partners with biopharma companies to accelerate the delivery of advanced‑therapy medicines. Drawing on decades of breakthroughs in manufacturing, analytical science and process development, VLE provides pragmatic, end‑to‑end CMC solutions – from early‑stage technology transfer through to GMP‑compliant production – ensuring that new treatments reach patients with the speed regulators require and the precision the market demands.

The company’s core services include GMP manufacturing, analytical testing, process optimisation and regulatory support for complex biologics and cell‑based therapies. Recent expansion of the Medicine Accelerators campus, a €100 million investment creating 300 new jobs, underlines VLE’s commitment to scaling capacity and innovation across its Dublin and Boston sites, with a worldwide footprint that serves both emerging and established developers.

By redefining the CMC journey for every medicine, VLE Therapeutics helps its clients focus on discovery while it handles the technical and regulatory rigour of bringing advanced therapies to market.